Skip to main content
SpringerLink
Log in
Book cover

Thérapeutique du cancer pp 99–110Cite as

Contrôle local et à distance des cancers

  • Chapter

  • 754 Accesses

Résumé

Lors de leur présentation initiale, environ 30 % des tumeurs malignes solides sont d’emblée métastatiques, généralement incurables. Pour les autres, tumeurs locales ou locorégionales, le traitement curateur sera assuré par la chirurgie dans 60 % des cas, la radiothérapie dans 30 %, et la chimiothérapie dans 5 % [1]. Malgré un traitement apparemment curateur, environ la moitié des patients vont présenter une récidive locorégionale dans le site initial de la tumeur, ou une métastase, à distance.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. van der Schueren E, Kesteloot K, Cleemput I (2000) Federation of European Cancer Societies. Full report. Economic evaluation in cancer care: questions and answers on how to alleviate conflicts between rising needs and expectations and tightening budgets. Eur J Cancer 36: 13–36

    Article  PubMed  Google Scholar 

  2. Halsted WS (1907) I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. Ann Surg 46: 1–19

    Article  PubMed  CAS  Google Scholar 

  3. Fisher B (1977) Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer 40(1 Suppl): 574–587

    Article  PubMed  CAS  Google Scholar 

  4. Fisher B (1980) Laboratory and clinical research in breast cancer—a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res 40: 3863–3874

    PubMed  CAS  Google Scholar 

  5. Daly-Schveitzer N (2008) Cancérologie clinique. Paris: Elsevier Masson

    Google Scholar 

  6. de Bock GH, Putter H, Bonnema J et al. (2009) The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model. Breast Cancer Res Treat 117: 401–408

    Article  PubMed  CAS  Google Scholar 

  7. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563–572

    Article  PubMed  CAS  Google Scholar 

  8. Luzzi KJ, MacDonald IC, Schmidt EE et al. (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153: 865–873

    Article  PubMed  CAS  Google Scholar 

  9. Norton L, Massague J (2006) Is cancer a disease of self-seeding? Nat Med 12: 875–878

    Article  PubMed  CAS  Google Scholar 

  10. Ye QH, Qin LX, Forgues M et al. (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9: 416–423

    Article  PubMed  CAS  Google Scholar 

  11. van de Vijver MJ, He YD, van’t Veer LJ et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999–2009

    Article  PubMed  Google Scholar 

  12. Paik S, Shak S, Tang G et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817–2613.

    Article  PubMed  CAS  Google Scholar 

  13. Chiang AC, Massague J (2008) Molecular basis of metastasis. N Engl J Med 359: 2814–2823

    Article  PubMed  CAS  Google Scholar 

  14. Early Breast Cancer Trialists’ Collaborative Group(1995) Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333: 1444–1455

    Article  Google Scholar 

  15. Cuzick J, Stewart H, Rutqvist L, Houghton J et al. (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12: 447–453

    PubMed  CAS  Google Scholar 

  16. Early breast cancer trialists’ collaborative group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687–1717

    Article  Google Scholar 

  17. Fisher B, Jeong JH, Anderson S et al. (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347: 567–575

    Article  PubMed  Google Scholar 

  18. Fisher B, Anderson S, Bryant J et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347: 1233–1241

    Article  PubMed  Google Scholar 

  19. SEER Cancer Statistics Review, 1975–2006, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2006

    Google Scholar 

  20. Overgaard M, Hansen PS, Overgaard J et al. (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337: 949–955

    Article  PubMed  CAS  Google Scholar 

  21. Ragaz J, Olivotto IA, Spinelli JJ et al. (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97: 116–126

    Article  PubMed  Google Scholar 

  22. Nielsen HM, Overgaard M, Grau CJ et al. (2006) Loco-regional recurrence after mastectomy in high-risk breast cancer—risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol 79: 147–155

    Article  PubMed  Google Scholar 

  23. Overgaard M, Jensen MB, Overgaard J et al. (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353: 1641–1648

    Article  PubMed  CAS  Google Scholar 

  24. Clarke M, Collins R, Darby S et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087–2106

    PubMed  CAS  Google Scholar 

  25. PORT Meta-analysis Trialists Group (1998) Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352: 257–263

    Article  Google Scholar 

  26. Marks LB, Prosnitz LR (2000) Postoperative radiotherapy for lung cancer: the breast cancer story all over again. Int J Radiat Oncol Biol Phys 48: 625–727.

    Article  PubMed  CAS  Google Scholar 

  27. Rosenberg SA, Kaplan HS (1985) The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin’s disease: 1962–1984. Int J Radiat Oncol Biol Phys 11: 5–22

    Article  PubMed  CAS  Google Scholar 

  28. Pole JG, Casper J, Elfenbein J et al. (1991) High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9: 152–158

    PubMed  CAS  Google Scholar 

  29. Castleberry RP, Smith EI, Cantor A et al. (1991) Surgico-pathologic staging of neuroblastoma. J Clin Oncol 9: 189

    PubMed  CAS  Google Scholar 

  30. Slotman B, Faivre-Finn C, Kramer G et al. (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357: 664–672

    Article  PubMed  CAS  Google Scholar 

  31. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13: 8–10

    PubMed  CAS  Google Scholar 

  32. Kern PA, Pass HI, Roth JA (1987) Surgical treatment of pulmonary metastases. In: Rosenberg SA (ed) Surgical treatment of metastatic cancer, JB Lippincott, Philadelphia, p 69–100

    Google Scholar 

  33. Fong Y, Salo J (1999) Surgical therapy of hepatic colorectal metastasis. Semin Oncol 26: 514–523

    PubMed  CAS  Google Scholar 

  34. Minagawa M, Makuuchi M, Torzilli G et al. (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231: 487–499

    Article  PubMed  CAS  Google Scholar 

  35. Moertel CG (1994) Chemotherapy for colorectal cancer. N Engl J Med 330: 1136–1142

    Article  PubMed  CAS  Google Scholar 

  36. Slotman BJ, Solberg TD, Verellen D (2006) Extracranial stereotactic radiotherapy and radiosurgery. Taylor & Francis, New York

    Google Scholar 

  37. Kavanagh BD, Timmerman RD (2005) Stereotactic body radiation therapy. Lippincott Williams & Wilkins, Philadelphie

    Google Scholar 

  38. Sobin LH, Wittekind C (2002) TNM Classification of malignant tumours, John Wiley & Sons, Hoboken

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de radiothérapie, Centre François-Georges Leclerc, 1 rue Professeur-Marion, 21079, Dijon Cedex

    G. Créhange & P. Maingon

  2. Service d’oncologie médicale, Centre Georges-François Leclerc, 1, rue Professeur-Marion, 21079, Dijon Cedex

    F. Ghiringhelli

  3. Service d’oncologie et de radiothérapie, CHU Jean Minjoz, 2, boulevard Alexandre-Flemming, 25030, Besançon Cedex

    J.-F. Bosset

Authors
  1. G. Créhange
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Ghiringhelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Maingon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J.-F. Bosset
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France

About this chapter

Cite this chapter

Créhange, G., Ghiringhelli, F., Maingon, P., Bosset, JF. (2011). Contrôle local et à distance des cancers. In: Thérapeutique du cancer. Springer, Paris. https://doi.org/10.1007/978-2-8178-0021-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0021-9_7

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0020-2

  • Online ISBN: 978-2-8178-0021-9

Publish with us

Policies and ethics

Search

Navigation